| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |